Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension

PLoS One. 2018 Sep 20;13(9):e0204254. doi: 10.1371/journal.pone.0204254. eCollection 2018.

Abstract

Although oxygen therapy rapidly improves arterial oxygen saturation in idiopathic pulmonary arterial hypertension, the effects of chronic administration of oxygen are unknown. The purpose of the present study was to investigate the effects of chronic oxygen therapy on the histological changes and survival rate in rats with idiopathic pulmonary arterial hypertension. Idiopathic pulmonary arterial hypertension was induced by monocrotaline injection. The rats were then randomly assigned to receive or not receive oxygen therapy (O2 group and non-O2 group, respectively). The rats in the O2 group were exposed to a high (90%) oxygen environment from day 17 following injection of monocrotaline, when hypoxemia was first observed. The pulmonary arteriole walls were significantly thicker in monocrotaline-injected rats than in saline-injected rats as vehicle on day 19 and were significantly thicker in the rats that received oxygen therapy than in the rats that did not. Right ventricular inflammations were significantly higher in monocrotaline-injected rats than in saline-injected rats on day 19 and were significantly higher in the rats that received oxygen therapy than in the rats that did not. By day 20 after injection of monocrotaline, the survival rate was significantly lower in the rats that received oxygen therapy than in those that did not. Superoxide dismutase activity in the lungs was higher in monocrotaline-injected rats than in saline-injected rats on day 19 after monocrotaline injection and was also higher in the saline-injected rats that received oxygen therapy than in the saline-injected rats that did not. No interaction was detected between monocrotaline injection and oxygen therapy. These results suggest that chronic oxygen therapy worsens the histological changes and survival rate in idiopathic pulmonary arterial hypertension. The fact that degradation of the histological changes and survival rate was accompanied by increase in superoxide dismutase activity suggests that antioxidant capacity may contribute to the degradation.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Hypertension, Pulmonary / chemically induced
  • Hypertension, Pulmonary / metabolism
  • Hypertension, Pulmonary / mortality*
  • Hypertension, Pulmonary / therapy
  • Male
  • Monocrotaline / adverse effects*
  • Oxygen Inhalation Therapy / adverse effects*
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / pathology*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Superoxide Dismutase / metabolism
  • Survival Rate

Substances

  • Monocrotaline
  • Superoxide Dismutase

Grants and funding

The author(s) received no specific funding for this work.